000 | 01512 a2200409 4500 | ||
---|---|---|---|
005 | 20250514002940.0 | ||
264 | 0 | _c20010927 | |
008 | 200109s 0 0 eng d | ||
022 | _a0889-2229 | ||
024 | 7 |
_a10.1089/088922201750251981 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRiddell, L A | |
245 | 0 | 0 |
_aA phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. _h[electronic resource] |
260 |
_bAIDS research and human retroviruses _cJun 2001 |
||
300 |
_a789-97 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xprevention & control |
650 | 0 | 4 |
_aAnti-Infective Agents _xadverse effects |
650 | 0 | 4 | _aConsumer Product Safety |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aHIV-1 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xadverse effects |
650 | 0 | 4 | _aRecombinant Proteins |
700 | 1 | _aPinching, A J | |
700 | 1 | _aHill, S | |
700 | 1 | _aNg, T T | |
700 | 1 | _aArbe, E | |
700 | 1 | _aLapham, G P | |
700 | 1 | _aAsh, S | |
700 | 1 | _aHillman, R | |
700 | 1 | _aTchamouroff, S | |
700 | 1 | _aDenning, D W | |
700 | 1 | _aParkin, J M | |
773 | 0 |
_tAIDS research and human retroviruses _gvol. 17 _gno. 9 _gp. 789-97 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/088922201750251981 _zAvailable from publisher's website |
999 |
_c11358506 _d11358506 |